Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for KHRN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 28, 2020 06:55 ET
Khiron To Present at Canaccord Genuity Virtual US Cannabis Symposium on September 30th
TORONTO, Sept. 28, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that Alvaro Torres, Khiron CEO and Director, and Chris Naprawa, Khiron Chairman, will present live at Canaccord Genuity's 2020 Virtual US Cannabis Symposium on September 30, 2020.
Read full article
Sep 24, 2020 13:34 ET
Khiron Becomes First Company to Sell Medical Cannabis in Peru, and Surpasses 3,000 Prescriptions in Colombia
First prescriptions for Khiron's medical cannabis in Peru are filled as the Company surpasses 3,000 medical cannabis prescription milestone in Colombia Khiron becomes the first Company to sell and fill medical cannabis prescriptions through private pharmacies in Peru The Company began sales in Peru with full spectrum High CBD supplied by Khiron Colombia and distributed to patients under the previously announced agreement with Farmacia Universal S.A.C. Farmacia Universal is an established pharmacy chain, with 10 locations in Lima Quotas for Khiron's high THC medical cannabis have also been ap
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
6.06
8.83
9.84
Price to Book - most recent quarter
0.93
1.86
2.88
Price to Cash Flow per share - TTM
--
7.30
10.78
Price to Free Cash Flow per share - TTM
--
8.52
16.48
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 202068,964-8,105
Aug 31, 202077,06931,574
Aug 15, 202045,495-332,839
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Khiron Life Sciences Corp, formerly Adent Capital Corp, is a Canada-based company engaged in alternative medicine sector. The Company is an integrated medical cannabis company with its core operations in Latin America. Khiron is active in the research area in medical cannabis industry. It develops and commercializes medical cannabis products mainly in Colombia.

See business summary

 

Twitter

Search (past week) for $KHRN.CA KHRN.V